A RANDOMISED, OPEN-LABEL PHASE III TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF BEXAROTENE (TARGRETIN) CAPSULES COMBINED WITH PUVA, COMPARED TO PUVA TREATMENT ALONE IN PATIENTS WITH MYCOSIS FUNGOIDES.

Registry ID

EUCTR2004-003701-24

Source registry

EUCTR

Status

Completed

Phase

PHASE3

Sponsor

E.O.R.T.C. - EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER

Start date

2004-12-10

Last update

2026-08-16

Conditions

• CUTANEOUS T CELL LYMPHOMA.
• Patients suffering from histopathologically documented Mycosis Fungoides, clinical stage Ib-IIa

Summary

CUTANEOUS T CELL LYMPHOMA.

Locations

• , , Denmark
• , , Italy

View on source registry